Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Adrian Adams
AddedMar 31, 2024
UpdatedMay 31, 2026
Adrian Adams

Adrian Adams

Board Member, AcelRx Pharmaceuticals

CrunchbaseLinkedIn

Adrian Adams's Career

AcelRx Pharmaceuticals
AcelRx Pharmaceuticals

Redwood City, CA, US

Board Member· Board
Impel Pharmaceuticals
Impel Pharmaceuticals

Seattle, WA, US

Board Member· Board
Akebia Therapeutics
Akebia Therapeutics

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Adrian Adams's Career

AcelRx Pharmaceuticals
AcelRx Pharmaceuticals
Acquired02005Redwood City, CA, US
Board Member· Board

Leadership at AcelRx Pharmaceuticals

Pamela PalmerPamela PalmerFounder
Vincent J. AngottiVincent J. AngottiCEO
Mark WanMark WanBoard Member
Steve HoffmanSteve HoffmanBoard Member

Similar to AcelRx Pharmaceuticals

Axsome TherapeuticsAxsome TherapeuticsNew York City, NY, USTherapeuticsest. 2012Axsome TherapeuticsNew York City, NY, US · est. 2012

American biopharmaceutical firm, Axsome Therapeutics, develops therapies for pain and neurological disorders globally.

Public · $432M383
Acadia PharmaceuticalsAcadia PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 1993Acadia PharmaceuticalsSan Diego, CA, US · est. 1993

ACADIA Pharmaceuticals: A San Diego-based biopharmaceutical company specializing in CNS disorder treatments.

Public513
TalpheraTalpheraRedwood City, CA, USPain Management, Pharmaceuticalsest. 2005TalpheraRedwood City, CA, US · est. 2005

Talphera, a specialty pharmaceutical firm in Redwood City, develops and commercializes therapies, including innovative pain management systems.

Public · $191.7M37
AkelosAkelosNew York City, NY, USDrug Developmentest. 2018AkelosNew York City, NY, US · est. 2018

Akelos, a NY-based biopharmaceutical company, develops innovative non-opioid drugs for neuropathic pain treatment.

Seed · $2.1M5
Impel Pharmaceuticals
Impel Pharmaceuticals
Public1192008Seattle, WA, US
Board Member· Board

Leadership at Impel Pharmaceuticals

Mahendra G. ShahMahendra G. ShahBoard Member
John HoekmanJohn HoekmanBoard Member
Timothy S. NelsonTimothy S. NelsonBoard Member
Robert MittendorffRobert MittendorffBoard Member
Aaron RoystonAaron RoystonBoard Member
H ParkerH ParkerBoard Member

Similar to Impel Pharmaceuticals

Neurana PharmaceuticalsNeurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5
Supernus PharmaceuticalsSupernus PharmaceuticalsRockville, MD, USPharmaceuticalsest. 2005Supernus PharmaceuticalsRockville, MD, US · est. 2005

US-based Supernus Pharmaceuticals develops and markets proprietary drugs for central nervous system disorders.

Public · $689.5M612
ARS PharmaceuticalsARS PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2015ARS PharmaceuticalsSan Diego, CA, US · est. 2015

ARS Pharmaceuticals: Innovating intranasal epinephrine sprays for allergy relief in Washington.

Public · $75M53
PIN PharmaPIN PharmaNew York City, NY, USPharmaceuticalsest. 2011PIN PharmaNew York City, NY, US · est. 2011

PIN Pharma: A venture-backed biopharmaceutical firm specializing in immune modulators for diverse health conditions.

Series A · $6.8M1
Akebia Therapeutics
Akebia Therapeutics
Public$442.5M2052007Cambridge, MA, US
Board Member· Board

Leadership at Akebia Therapeutics

LeAnne M. ZumwaltLeAnne M. ZumwaltBoard Member
Michael HeffernanMichael HeffernanBoard Member
Joseph GardnerJoseph GardnerCo-Founder
Michael RogersMichael RogersBoard Member
Robert ShalwitzRobert ShalwitzCo-Founder
Steven C. GilmanSteven C. GilmanBoard Member

Adrian Adams's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Adrian Adams

Greg GilmanGreg GilmanCo-Founder · Science BlockchainJohn KelleyJohn KelleyBoard Member · Acorda TherapeuticsAlbert ChaAlbert ChaBoard Member · AirXpandersSteve AselageSteve AselageBoard Member · Travere TherapeuticsB. Lynne ParshallB. Lynne ParshallBoard Member · Ionis Pharmaceuticals